TCL Archive Nurses’ Work Environment Needs Change To Protect Patients From Errors, IOM Says November 28, 2003
TCL Archive Carter In Last Budget Asks Four Percent Increase For NCI, But Then Seeks $13.5 Million Rescission January 23, 1981
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure December 5, 2014
